IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia ...
Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...
Stocks Trim Losses On Mexico Tariff Delay, Gold Extends Records, Tesla Sinks 6%: What's Driving Markets Monday? Wall Street bounced back after President Donald Trump and Mexican President Claudia ...
IDEXX Laboratories, Inc. (NASDAQ:IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market ...
Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...
Idexx Laboratories (IDXX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.40 per share. This compares to earnings of $2.32 per share a year ago.
Barclays raised the firm’s price target on Idexx Laboratories (IDXX) to $520 from $481 and keeps an Overweight rating on the shares. The company reported a Q4 beat and “healthy” 2025 revenue guidance, ...
Shares of IDEXX Laboratories Inc. IDXX slid 3.31% to $444.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to 6,114.63 ...
Idexx Laboratories (IDXX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Daniel Clark from Leerink Partners reiterated a Buy rating ...
Early data shows IDEXX Cancer Dx testing can detect lymphoma before clinical signs are present, 5 supporting its utility in routine preventive care for at-risk dogs. "Building on over 40 years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results